Funded Startups in Neuchatel
Among the 11 most recent Neuchâtel-area rounds shown (2021-10-01 to 2026-03-04), the only disclosed amount above $50M is Hilo’s $42M round on 2025-05-01, w…
Among the 11 most recent Neuchâtel-area rounds shown (2021-10-01 to 2026-03-04), the only disclosed amount above $50M is Hilo’s $42M round on 2025-05-01, which is a clear outlier versus the rest of the disclosed amounts clustered below $30M (with the next-largest disclosed being Novostia at $7M on 2024-09-09). Stage and disclosure also skew heavily toward incomplete terms: 5 of 11 entries are “Series Unknown,” and 2 additional entries show “undisclosed” amounts (SOLARSPLIT on 2024-06-05; MimiX Biotherapeutics on 2023-10-16).
Timing concentrates in the recent quarters: 5 of 11 rounds fall between 2024-02-13 and 2024-09-09, and another 3 fall in 2025 (NovoViz $120K on 2025-05-08; Hilo $42M on 2025-05-01). The geography is consistently Neuchâtel, Neuchatel, Switzerland across all rows, with sectors spread but “Artificial Intelligence (AI)” appearing in multiple entries (Hilo on 2025-05-01 and SOLARSPLIT on 2024-06-05).
Most recent rounds
11 of 121 more funded startups
This page shows the 11 most recent rounds (back to Oct 2021). The full 12-company history for this listing is available on a paid plan.
Unlock all 12 companies in this listing — full funding history, investors, and founders.
Related listings
Frequently asked
What stands out on round size in the Neuchâtel list, and how extreme is the gap?
Hilo’s $42M round on 2025-05-01 is the standout disclosed amount in these rows; everything else with disclosed value is at or below Novostia’s $7M on 2024-09-09. In contrast, the smaller disclosed checks include Symactiv’s $130K (2026-03-04) and Senbiosys’s $580K (2023-03-14).
Do any companies or industries show over-representation in this slice of Neuchâtel funding?
“Artificial Intelligence (AI)” appears in multiple entries: Hilo (Series B, $42M on 2025-05-01) and SOLARSPLIT (Series Unknown, undisclosed amount on 2024-06-05). Beyond that, other sectors show up once each in the rows shown, including Blockchain and Cryptocurrency (Nym Technologies, $150K on 2024-02-13) and Biotechnology (MimiX Biotherapeutics, undisclosed on 2023-10-16).
How concentrated are the dates, and what does the recent window look like?
The 11 rows span 2021-10-01 (Travizory Border Security SA, $2M, Convertible Note) through 2026-03-04 (Symactiv, $130K). Within that range, 5 rounds are dated between 2024-02-13 and 2024-09-09 (including Aktiia $30M on 2024-02-27 and Novostia $7M on 2024-09-09), and 3 rounds occur in 2025 (NovoViz $120K on 2025-05-08, Hilo $42M on 2025-05-01, and no other 2025 entries shown).
What stage and disclosure mix dominates across these 11 entries?
Stage labels are frequently non-specific: 5 of 11 entries are “Series Unknown” (e.g., Symactiv 2026-03-04 for $130K and NovoViz 2025-05-08 for $120K). Amount disclosure is also incomplete: 2 entries list “undisclosed” amounts (SOLARSPLIT on 2024-06-05 and MimiX Biotherapeutics on 2023-10-16).
Are there notable lower-end amounts or seed-level checks that differ from the main funding pattern?
Several disclosed rounds sit well below the largest check: Infrascreen is a $2M Seed on 2022-05-03, Travizory Border Security SA is $2M Convertible Note on 2021-10-01, and Symactiv’s $130K (2026-03-04) contrasts with the mid-teens-to-millions cluster seen in other disclosed rounds like Nym Technologies $150K (2024-02-13) and Senbiosys $580K (2023-03-14).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.